Quick Answer
ENvue Medical, Inc. reported Total Assets of $3.63 million for the year ending 2024.
- ENvue Medical, Inc. showed a decrease of -45.6% in Total Assets from 2023 to 2024.
- This data is from ENvue Medical, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2014 to 2024 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: $2.63 million | Q3 2015: $2.35 million | Q1 2016: $1.65 million | Q2 2016: $1.24 million | Q3 2016: $924.0 thousand | Q1 2017: $446.0 thousand | Q2 2017: $757.0 thousand | Q3 2017: $809.0 thousand | Q1 2018: $3.98 million | Q2 2018: $3.17 million | Q3 2018: $2.43 million | Q1 2019: $817.0 thousand | Q2 2019: $3.11 million | Q3 2019: $3.07 million | Q1 2020: $1.12 million | Q3 2020: $4.10 million | Q1 2021: $8.60 million | Q2 2021: $6.83 million | Q3 2021: $9.67 million | Q1 2022: $7.66 million | Q2 2022: $6.54 million | Q3 2022: $5.21 million | Q1 2023: $4.81 million | Q2 2023: $3.83 million | Q3 2023: $7.36 million | Q1 2024: $6.24 million | Q2 2024: $5.70 million | Q3 2024: $4.68 million | Q4 2024: $3.63 million | Q1 2025: $44.11 million | Q2 2025: $51.48 million | Q3 2025: $54.38 million.
- Over the full 11 years of available data (2014 to 2024), ENvue Medical, Inc.'s Total Assets has grown by 401.9%.
- Historical annual values: Fiscal year 2024: $3.63 million | Fiscal year 2023: $6.67 million | Fiscal year 2022: $5.88 million | Fiscal year 2021: $8.62 million | Fiscal year 2020: $8.23 million | Fiscal year 2019: $2.04 million | Fiscal year 2018: $1.58 million | Fiscal year 2017: $4.87 million | Fiscal year 2016: $494.0 thousand | Fiscal year 2015: $1.98 million | Fiscal year 2014: $723.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: